Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

WELL Health Technologies Corp

Healthcare CA WELL

4.84CAD
-0.21(4.16%)

Last update at 2026-06-05T20:00:00Z

Day Range

4.815.02
LowHigh

52 Week Range

3.586.08
LowHigh

Fundamentals

  • Previous Close 5.05
  • Market Cap1116.38M
  • Volume1615346
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA166.69M
  • Revenue TTM1400.18M
  • Revenue Per Share TTM5.54
  • Gross Profit TTM 618.84M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 5.31M 8.99M 19.88M 17.92M -24.76500M
Minority interest -11.82200M 3.51M -16.55500M -17.30600M -12.89200M
Net income -50.20900M 32.61M 0.08M 19.07M -30.68600M
Selling general administrative 339.87M 321.47M 212.69M 176.41M 107.75M
Selling and marketing expenses 92.51M - 64.29M 47.70M 15.78M
Gross profit 525.08M 363.01M 311.50M 303.29M 153.69M
Reconciled depreciation 93.76M 72.31M 60.77M 55.20M 38.22M
Ebit 113.03M - 41.11M 22.11M -6.70300M
Ebitda 206.79M - 101.88M 77.31M 32.01M
Depreciation and amortization 93.76M - 60.77M 55.20M 38.71M
Non operating income net other - - - - -
Operating income 113.03M -54.87900M 41.11M 23.31M -6.20900M
Other operating expenses 1287.15M - 734.95M 545.15M 310.37M
Interest expense 54.47M 0.57M 31.34M 22.34M 7.55M
Tax provision 0.85M -20.10400M 2.86M -1.15000M 5.92M
Interest income 1.72M 61.53M 0.76M 0.65M 2.20M
Net interest income -56.16300M -35.60900M -31.55700M -22.21400M -7.26300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.85M - 2.86M -1.15000M 5.92M
Total revenue 1400.18M 919.69M 776.05M 569.14M 302.32M
Total operating expenses 412.05M 950.45M 270.39M 279.31M 161.74M
Cost of revenue 875.10M 556.68M 464.56M 265.85M 148.63M
Total other income expense net -107.72300M 75.37M -21.23400M -5.39000M -18.55600M
Discontinued operations - - - - -
Net income from continuing ops 4.46M 29.10M 16.64M 18.68M -30.89500M
Net income applicable to common shares - 32.61M 0.08M 1.37M -43.78700M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2096.89M 1807.27M 1409.30M 1319.03M 1262.42M
Intangible assets 760.21M 573.96M 555.20M 571.27M 405.52M
Earning assets - - - - -
Other current assets 30.76M 1.68M 21.58M 0.52M 3.68M
Total liab 1057.49M 877.55M 563.16M 503.78M 554.37M
Total stockholder equity 863.51M 867.61M 767.67M 732.34M 618.24M
Deferred long term liab - - - - -
Other current liab 106.84M 8.64M 37.45M 35.72M 75.69M
Common stock 808.06M - 751.55M 705.19M 633.51M
Capital stock 808.06M 784.87M 751.55M 705.19M 633.51M
Retained earnings -38.33500M -30.97500M -63.58400M -63.66600M -64.64300M
Other liab - - - 52.12M 72.51M
Good will 787.62M 565.12M 508.06M 499.29M 611.75M
Other assets - - - 3.18M 2.85M
Cash 133.75M 131.67M 43.42M 48.91M 61.92M
Cash and equivalents - - - 48.91M 61.92M
Total current liabilities 357.47M 382.08M 152.95M 136.50M 137.30M
Current deferred revenue 49.41M - 6.65M 6.80M 4.24M
Net debt 577.21M 213.69M 382.86M 309.51M 340.02M
Short term debt 109.62M - 60.98M 43.26M 57.37M
Short long term debt 89.94M 9.38M 46.11M 34.15M 50.15M
Short long term debt total 710.96M - 426.28M 358.42M 401.94M
Other stockholder equity - - 54.05M 51.77M 43.99M
Property plant equipment - - - 82.53M 88.55M
Total current assets 369.61M 346.11M 176.40M 150.88M 142.91M
Long term investments 19.04M 173.79M 60.86M 10.01M 10.85M
Net tangible assets - - - -338.21300M -399.02800M
Short term investments - - - - -
Net receivables 202.62M 184.50M 110.21M 95.85M 71.82M
Long term debt 420.65M 335.98M 298.91M 263.00M 290.60M
Inventory 2.46M 2.69M 1.18M 1.37M 0.79M
Accounts payable 91.60M 86.58M 47.88M 50.73M 38.67M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 93.78M - 25.65M 39.06M 5.38M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 7.74M 3.54M 4.39M 5.06M 2.85M
Deferred long term asset charges - - - - -
Non current assets total 1727.28M 1461.16M 1232.91M 1168.15M 1119.52M
Capital lease obligations 90.05M 79.73M 81.26M 61.26M 61.19M
Long term debt total - - - 315.16M 344.57M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -60.22600M -81.31500M -37.92600M -3.12300M
Change to liabilities - - - 10.14M 1.20M
Total cashflows from investing activities -111.73800M -60.22600M -81.31500M -37.92600M -499.77800M
Net borrowings 73.62M - - -58.75000M 171.07M
Total cash from financing activities 0.94M 133.50M 39.58M -52.84700M 452.53M
Change to operating activities - - - -6.73500M 0.21M
Net income -7.36000M 29.10M 0.08M 18.68M -30.89500M
Change in cash -131.66900M 88.25M -5.48500M -13.01100M -24.97100M
Begin period cash flow 131.67M 43.42M 48.91M 61.92M 86.89M
End period cash flow 133.75M 131.67M 43.42M 48.91M 61.92M
Total cash from operating activities 115.79M 10.22M 62.59M 76.55M 22.27M
Issuance of capital stock 58.32M 47.65M 0.00000M 34.51M 302.50M
Depreciation 93.76M 72.31M 60.77M 55.20M 38.22M
Other cashflows from investing activities -91.53400M -44.00000M -73.20800M -31.52200M -25.54000M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 0.23M -1.51100M 0.19M -0.57700M 0.88M
Change to account receivables 47.30M - -2.48500M -9.37000M -13.27100M
Sale purchase of stock -1.82600M 49.21M 0.81M -0.24300M 303.13M
Other cashflows from financing activities -155.27500M 133.63M -25.10100M 21.10M 191.22M
Change to netincome - - - - 37.86M
Capital expenditures 27.87M 16.23M 25.38M 6.40M 2.68M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -36.70200M 6.67M -10.24900M -6.05800M -11.19600M
Stock based compensation 22.69M 15.27M 26.16M 24.48M 21.01M
Other non cash items 82.47M 20.84M -3.75500M -14.77900M 4.09M
Free cash flow 87.92M -6.70400M 37.20M 70.14M 19.59M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
WELL
WELL Health Technologies Corp		 -0.21 4.16% 4.84 - 13.87 0.80 1.23 1.09 9.83
EXE
Extendicare Inc		 1.07 3.34% 33.14 25.21 23.92 1.59 7.26 1.62 14.43
SIA
Sienna Senior Living Inc		 0.42 1.98% 21.58 45.94 38.17 2.23 3.17 3.57 21.90
DR
Medical Facilities Corporation		 0.58 3.23% 18.51 15.57 12.94 1.18 2.87 0.92 3.64
AIDX
HealWELL AI Inc.		 -0.03 3.33% 0.87 - - 2.81 2.35 3.46 -4.9271

Reports Covered

Stock Research & News

View All

Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.

WELL Health Technologies Corp

375 Water Street, Vancouver, BC, Canada, V6B 5C6

Key Executives

Name Title Year Born
Mr. Hamed Shahbazi B.Sc., BSc Founder, Chairman & CEO 1975
Ms. Eva Fong Chief Financial Officer NA
Mr. Amir Javidan Chief Operating Officer NA
Mr. Brian Eric Levinkind Sr. VP of Corp. Devel. 1966
Dr. Michael Frankel Chief Medical Officer NA
Mr. Arjun Kumar Chief Information Officer NA
Mr. Pardeep S. Sangha M.B.A. VP of Corp. Strategy & Investor Relations NA
Mr. Chris Ericksen Sr. VP of Strategic Partnerships & Marketing NA
Mr. Shane Joseph Sabatino Chief People Officer NA
Ms. Sara Bond Sr. VP of Product Devel. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions